Cervical Transforaminal Injection of Steroids Guided by Ultrasound
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Cervical transforaminal epidural steroid injections (TFESI) are indicated in cervical radicular pain resistant to conservation therapy, by which steroids can be delivered into anterior epidural space surrounding target spinal nerve roots to help alleviate pain in the upper limb or neck. Cervical TFESI is traditionally commended to perform with guidance of fluoroscopy or CT. As fluoroscopy can not monitor the injection route whether it pass vessel or not, many serious neurological complications caused by inadvertent intra-arterial injection have been reported2. Here, the investigators will introduce a novel cervical TFESI guided by ultrasound, which incidence of inadvertent vessel injury or injection might be lower than those guided by fluoroscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 16, 2014
CompletedFirst Posted
Study publicly available on registry
November 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedNovember 21, 2014
November 1, 2014
1 year
November 16, 2014
November 19, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change of pain severity rated on a Visual Analog Scale (VAS)
1 day before, 1day after, 1week after and 4 weeks after the intervention
Secondary Outcomes (2)
change of neck actives rated on Neck Disability Index (NDI)
1 day before, 1day after, 1week after and 4 weeks after the intervention
change of medication use rated on Medication Quantitative Scale (MQS)
1 day before, 1day after, 1week after and 4 weeks after the intervention
Study Arms (3)
USNR steroid injection
EXPERIMENTALthe patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.
UCTF steroid injection
EXPERIMENTALthe patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.
XCTF steroid injection
EXPERIMENTALthe patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided only by C arm.
Interventions
deliver steroids (dexamethasone) into spinal nerve root with the guidance of ultrasound. Device: Ultrasound (S-Nerve; SonoSite, Bothell, Wash), Probe 9L (6 MHz, SonoSite, Bothell, Wash)
deliver steroids (dexamethasone) into spinal epidural space with the guidance of ultrasound. Device: Ultrasound (S-Nerve; SonoSite, Bothell, Wash), Probe 9L (6 MHz, SonoSite, Bothell, Wash)
One of the most efficient steroids
Ultrasound (S-Nerve; SonoSite, Bothell, Wash), Probe 9L (6 MHz, SonoSite, Bothell, Wash)
the needle position will be re-confirmed by C arm C arm (Philips Healthcare, Best, the Netherlands)
Eligibility Criteria
You may qualify if:
- evidence of a cervical radiculopathy involving 1 spinal nerve of at least 1 month's duration refractory to medical treatment
- symptoms of cervical pain radiating to the upper limb
- and signs of altered sensations, ab- normal reflexes, or motor weakness caused by degenerative spondylosis and/or disk herniation as documented at CT or MR imaging and a current mean pain VAS score of six.
You may not qualify if:
- evidence of vertebral fracture, tumor, or infection of the cervical spine
- treatment with cervical corticosteroid injections within the past 3 months
- coagulopathy
- allergy to iodinated contrast media.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pain Management Center
Study Record Dates
First Submitted
November 16, 2014
First Posted
November 20, 2014
Study Start
January 1, 2014
Primary Completion
January 1, 2015
Study Completion
March 1, 2015
Last Updated
November 21, 2014
Record last verified: 2014-11